Hospital and health center leaders are pushing back against President Donald Trump’s (R) new executive order, criticizing its controversial 340B [...] …
Category: Federal
Tariffs on Pharmaceuticals Could Worsen Drug Shortages, Cause Disarray in 340B Prices, Advocates Say
President Donald Trump’s (R) plan to place tariffs on foreign pharmaceuticals could destabilize 340B drugs’ prices unless drugmakers absorb the [...] …
The U.S. Department of Health and Human Services (HHS) should identify and implement ways to formally coordinate activities relating to [...] …
President Donald Trump (R) last night issued a wide-ranging health care executive order that revives a controversial 340B policy from [...] …
U.S. Department of Health and Human Services (HHS) officials last week briefed the Republican and Democratic staff of a key [...] …
Four major drug manufacturers and a drug industry vendor recently urged a Washington D.C. federal court to reject the government [...] …
Johnson & Johnson (J&J) added Ustekinumab, the unbranded version of psoriatic arthritis treatment Stelara, to its 340B contract pharmacy restrictions [...] …
The Trump administration’s recent efforts to restructure the Department of Health and Human Services (HHS)—including division consolidations and the elimination [...] …
The U.S. Senate voted along party lines Thursday to confirm Mehmet Oz—a celebrity heart surgeon known as “Dr. Oz” for [...] …
The leaders of a Senate panel that oversees several key federal health agencies this week invited Health and Human Services [...] …